Skip to main content
SpringerLink
Log in

Sarcoidosis

  • Chapter
European Handbook of Dermatological Treatments

  • 161 Accesses

Abstract

Sarcoidosis was first described by Sir Jonathan Hutchinson in 1875 and later in the skin as lupus pernio by Besnier in 1889 and as “multiple benign sarkoid of the skin” by Boeck in 1899. Sarcoidosis is a systemic granulomatous disorder of unknown cause. By Even the lung is most commonly affected, lymph nodes, lungs, liver, spleen, bones and eyes and especially the skin can be involved. Skin lesions could frequently appear as the first sign of disease (in up to 35 %) emphasising the important role of the dermatologist for the diagnosis and further investigations. Typically noncaseating epithelioid granulomas without surrounding lymphocytic infiltration can be found within affected organs histologically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bachelez H, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol. 2001;137(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  • Baughman RP, Lower EE. Leflunomide for chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21(1):43–8.

    PubMed  Google Scholar 

  • Baughman RP, et al. Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM. 2006a;99(5):307–15.

    Article  CAS  PubMed  Google Scholar 

  • Baughman RP, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006b;174(7):795–802.

    Article  CAS  PubMed  Google Scholar 

  • Besnier E. Lupus pernio de la face: synovites fongueuses symétriques des extrémités supérieures. Ann Dermatol Syphil. 1889;10:333–36.

    Google Scholar 

  • Boeck C. Multiple benign sarkoid of the skin. J Cutan Genitourin Dis. 1899;17:543–50.

    Google Scholar 

  • Burns AM, Green PJ, Pasternak S. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab. J Cutan Pathol. 2012;39(2):289–93.

    Article  PubMed  Google Scholar 

  • Demeter SL. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest. 1988;94(1):202–3.

    Article  CAS  PubMed  Google Scholar 

  • Denys BG, et al. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond). 2007;112(5):281–9.

    Article  CAS  Google Scholar 

  • Drake WP, et al. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA Dermatol. 2013;149(9):1040–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fazzi P, et al. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids. Biomed Pharmacother. 2012;66(4):300–7.

    Article  CAS  PubMed  Google Scholar 

  • Hutchinson J, ed. Illustrations of Clinical Surgery, Vol. 1, London: Churchill, 1878:42–43.

    Google Scholar 

  • Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol. 1990;23(3 Pt 1):487–9.

    Article  CAS  PubMed  Google Scholar 

  • Klein A, et al. Off-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study. J Eur Acad Dermatol Venereol. 2012;26(11):1400–6.

    Article  CAS  PubMed  Google Scholar 

  • Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci. 1990;299(3):153–7.

    Article  CAS  PubMed  Google Scholar 

  • Nguyen YT, et al. Treatment of cutaneous sarcoidosis with thalidomide. J Am Acad Dermatol. 2004;50(2):235–41.

    Article  PubMed  Google Scholar 

  • Schmitt CE, et al. Hypopigmented cutaneous sarcoidosis responsive to minocycline. J Drugs Dermatol. 2012;11(3):385–9.

    CAS  PubMed  Google Scholar 

  • Stagaki E, et al. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest. 2009;135(2):468–76.

    Article  PubMed  Google Scholar 

  • Steen T, English JC. Oral minocycline in treatment of cutaneous sarcoidosis. JAMA Dermatol. 2013;149(6):758–60.

    Article  PubMed  Google Scholar 

  • Tuchinda C, Wong HK. Etanercept for chronic progressive cutaneous sarcoidosis. J Drugs Dermatol. 2006;5(6):538–40.

    PubMed  Google Scholar 

  • Wanat KA, Rosenbach M. Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors. Arch Dermatol. 2012;148(9):1097–100.

    Article  PubMed  Google Scholar 

  • Wyser CP, et al. Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial. Am J Respir Crit Care Med. 1997;156(5):1371–6.

    Article  CAS  PubMed  Google Scholar 

Further Reading

  • Agbogu BN, et al. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol. 1995;52(9):875–9.

    Article  CAS  PubMed  Google Scholar 

  • Backer H, Landthaler M, Szeimies RM. Therapeutic strategies for cutaneous sarcoidosis. J Dtsch Dermatol Ges. 2005;3(4):284–97; quiz 298–300.

    Article  PubMed  Google Scholar 

  • Baughman RP, Lower EE. Evidence-based therapy for cutaneous sarcoidosis. Clin Dermatol. 2007;25(3):334–40.

    Article  PubMed  Google Scholar 

  • Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17(1):60–6.

    CAS  PubMed  Google Scholar 

  • Baughman RP, et al. Thalidomide for chronic sarcoidosis. Chest. 2002;122(1):227–32.

    Article  CAS  PubMed  Google Scholar 

  • Baughman RP, et al. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest. 2005;128(2):1062–47.

    Article  PubMed  Google Scholar 

  • Bhat P, et al. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm. 2009;17(3):185–90.

    Article  CAS  PubMed  Google Scholar 

  • Brechtel B, et al. Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol. 1996;135(2):307–9.

    Article  CAS  PubMed  Google Scholar 

  • Breuer K, et al. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters. Br J Dermatol. 2005;152(6):1290–5.

    Article  CAS  PubMed  Google Scholar 

  • Chaussenot A, et al. [Neurosarcoidosis treated with mycophenolate mofetil: two cases]. Rev Neurol (Paris). 2007;163(4):471–5.

    Article  CAS  Google Scholar 

  • Chong WS, Tan HH, Tan SH. Cutaneous sarcoidosis in Asians: a report of 25 patients from Singapore. Clin Exp Dermatol. 2005;30(2):120–4.

    Article  PubMed  Google Scholar 

  • Doherty CB, Rosen T. Evidence-based therapy for cutaneous sarcoidosis. Drugs. 2008;68(10):1361–83.

    Article  CAS  PubMed  Google Scholar 

  • Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127(3):1064–71.

    Article  CAS  PubMed  Google Scholar 

  • Field S, et al. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept. Clin Exp Dermatol. 2010;35(7):795–6.

    Article  CAS  PubMed  Google Scholar 

  • Gutzmer R, Kapp A, Werfel T. [Successful treatment of skin and lung sarcoidosis with fumaric acid ester]. Hautarzt. 2004;55(6):553–7.

    Article  CAS  PubMed  Google Scholar 

  • Haimovic A, et al. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol. 2012;66(5):699.e1–18; quiz 717–8.

    Article  Google Scholar 

  • Henderson CA, Ilchyshyn A, Curry AR. Laryngeal and cutaneous sarcoidosis treated with methotrexate. J R Soc Med. 1994;87(10):632–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hirsch JG. Experimental treatment with chloroquine. Am Rev Respir Dis. 1961;84((5)Pt 2):52–8.

    PubMed  Google Scholar 

  • Jung YJ, Roh MR. Clinical and histopathological analysis of specific lesions of cutaneous sarcoidosis in Korean patients. J Dermatol Treat. 2011;22(1):11–7.

    Article  Google Scholar 

  • Kouba DJ, et al. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol. 2003;148(1):147–8.

    Article  CAS  PubMed  Google Scholar 

  • Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155(8):846–51.

    Article  CAS  PubMed  Google Scholar 

  • Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):442–51.

    Article  PubMed  Google Scholar 

  • Martinet Y, et al. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am Rev Respir Dis. 1988;138(5):1242–8.

    Article  CAS  PubMed  Google Scholar 

  • Meissner M, et al. Dimethyl fumarate – only an anti-psoriatic medication? J Dtsch Dermatol Ges. 2012;10(11):793–801.

    PubMed  Google Scholar 

  • Miyazaki E, et al. Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect? Clin Rheumatol. 2008;27(9):1195–7.

    Article  PubMed  Google Scholar 

  • Morse SI, et al. The treatment of sarcoidosis with chloroquine. Am J Med. 1961;30:779–84.

    Article  CAS  PubMed  Google Scholar 

  • Moudgil A, Przygodzki RM, Kher KK. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol. 2006;21(2):281–5.

    Article  PubMed  Google Scholar 

  • Muller-Quernheim J, et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J. 1999;14(5):1117–22.

    Article  CAS  PubMed  Google Scholar 

  • Nowack U, et al. Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol. 2002;2:15.

    Article  PubMed  PubMed Central  Google Scholar 

  • Oswald-Richter KA, et al. Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol. 2012;32(5):1129–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pia G, et al. Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13(2):146–52.

    CAS  PubMed  Google Scholar 

  • Rosof BM. Letter: Allopurinol for sarcoid? N Engl J Med. 1976;294(8):447.

    CAS  PubMed  Google Scholar 

  • Siltzbach LE, Teirstein AS. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand Suppl. 1964;425:302–8.

    CAS  PubMed  Google Scholar 

  • Thielen AM, et al. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists. Dermatology. 2009;219(1):59–62.

    Article  CAS  PubMed  Google Scholar 

  • Utz JP, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003;124(1):177–85.

    Article  CAS  PubMed  Google Scholar 

  • Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol. 1977;97(2):213–6.

    Article  CAS  PubMed  Google Scholar 

  • Voelter-Mahlknecht S, et al. Treatment of subcutaneous sarcoidosis with allopurinol. Arch Dermatol. 1999;135(12):1560–1.

    Article  CAS  PubMed  Google Scholar 

  • Waldinger TP, et al. Treatment of cutaneous sarcoidosis with isotretinoin. Arch Dermatol. 1983;119(12):1003–5.

    Article  CAS  PubMed  Google Scholar 

  • Webster GF, et al. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol. 1991;24(3):451–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Venereology, Otto-von-Guericke University Magdeburg, Leipziger Strasse 44, D-39120, Magdeburg, Germany

    Sven R. Quist

Authors
  1. Sven R. Quist
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sven R. Quist .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Andreas Syggros Hospital University of Athens, Athens, Greece

    Andreas D. Katsambas  & Clio Dessinioti  & 

  2. University of Rome “G. Marconi”, Rome, Italy

    Torello M. Lotti

  3. Centro Studi per la Ricerca Multidisciplinare Rigenerativa (CSRMR), Rome, Italy

    Torello M. Lotti

  4. Unit of Dermatology, University of Pisa, Pisa, Italy

    Angelo Massimiliano D’Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Quist, S.R. (2015). Sarcoidosis. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_85

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45139-7_85

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45138-0

  • Online ISBN: 978-3-662-45139-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation